SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-07-195771
Filing Date
2007-09-05
Accepted
2007-09-05 17:19:33
Documents
14
Period of Report
2007-09-05
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d8k.htm 8-K 15366
2 NICVAX PRESS RELEASE dex991.htm EX-99.1 22857
3 WEBCAST SLIDES dex992.htm EX-99.2 96034
4 GRAPHIC g16735ex99_2s10gbgd.jpg GRAPHIC 27860
5 GRAPHIC g16735ex99_2s1gbgd.jpg GRAPHIC 44318
6 GRAPHIC g16735ex99_2s2gbgd.jpg GRAPHIC 26790
7 GRAPHIC g16735ex99_2s3gbgd.jpg GRAPHIC 27776
8 GRAPHIC g16735ex99_2s4gbgd.jpg GRAPHIC 28150
9 GRAPHIC g16735ex99_2s5gbgd.jpg GRAPHIC 42100
10 GRAPHIC g16735ex99_2s6gbgd.jpg GRAPHIC 42798
11 GRAPHIC g16735ex99_2s7gbgd.jpg GRAPHIC 39478
12 GRAPHIC g16735ex99_2s8gbgd.jpg GRAPHIC 41821
13 GRAPHIC g16735ex99_2s9gbgd.jpg GRAPHIC 27415
14 GRAPHIC g16735image002.jpg GRAPHIC 2046
  Complete submission text file 0001193125-07-195771.txt   620758
Mailing Address 5800 PARK OF COMMERCE BLVD NW STE 322 BOCA RATON FL 33487
Business Address 5800 PARK OF COMMERCE BLVD N W STE 322 BOCA RATON FL 33487 5619895800
NABI BIOPHARMACEUTICALS (Filer) CIK: 0000072444 (see all company filings)

IRS No.: 591212264 | State of Incorp.: DE | Fiscal Year End: 1225
Type: 8-K | Act: 34 | File No.: 000-04829 | Film No.: 071100604
SIC: 2836 Biological Products, (No Diagnostic Substances)